Finasteride improves male pattern hair loss in a randomized study in identical twins

European Journal of Dermatology

Volumn 12, Issue 1, 2002, Pages 32-37

  Stough, Dow B ^a   Rao, Naveen A ^a   Kaufman, Keith D ^a   Mitchell, Colleen ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Androgenetic alopecia; Finasteride; Identical twins; Male pattern hair loss

Indexed keywords

ANDROSTANOLONE; FINASTERIDE; PLACEBO; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; HAIR GROWTH; HUMAN; MALE; MALE TYPE ALOPECIA; MONOZYGOTIC TWINS; PATIENT SATISFACTION; PHOTOGRAPHY; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION; TESTOSTERONE BLOOD LEVEL;

ADULT; ALOPECIA; DIHYDROTESTOSTERONE; ENZYME INHIBITORS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FINASTERIDE; HAIR; HUMANS; MALE; MIDDLE AGED; PLACEBO EFFECT; QUESTIONNAIRES; TESTOSTERONE;

EID: 0036164539     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Male pattern baldness: Classification and incidence
2. Prevalence of male pattern hair loss in 18-49 year old men
3. Male hormone stimulation is prerequisite and an incitant in common baldness
4. Patterned loss of hair in man: Types and incidence
5. Steroid 5α-reductase deficiency in man: An inherited form of male pseudohermaphroditism
6. What is the right statistical measure of twin concordance (or diagnostic reliability and validity?)
7. Usefulness of the co-twin control design in investigations as exemplified in a study of effects of ascorbic acid on laboratory test results
8. Efficiency of human monozygotic twins in studies of blood lipids
9. "Partner control" method of twin studies in evaluating the hemodynamic effects of nonachlazine
10. Vitamin C and the common cold: Using identical twins as controls
11. Finasteride: A clinical review
12. Identification and selective inhibition of an isozyme of steroid 5a-reductase in human scalp
13. Hormonal effects of a 5 alpha-reductase inhibitor (finasteride) on hormonal levels in normal men and in patients with benign prostatic hyperplasia
14. Finasteride, an inhibitor of 5α-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia
15. The effect of finasteride, a 5α-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness
16. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia
17. Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss
18. Finasteride in the treatment of men with androgenetic alopecia
19. Finasteride in the treatment of men with frontal male pattern hair loss
20. Finasteride: A review of its use in male pattern hair loss
21. Photographic documentation of hair growth in androgenetic alopecia
22. A hair growth questionnaire for use in the evaluation of therapeutic effects in men
23. Finasteride increases anagen hair in men with androgenetic alopecia
24. Reproducibility of global photographic assessments of patients with male pattern baldness in a clinical trial with finasteride
25. Long-term (5 years) multinational experience with finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss)
26. US product circular for PROPECIA® (finasteride 1 mg tablets)
27. The effects of hair loss in European men: A survey in four countries
28. The psychosocial consequences of androgenetic alopecia: A review of the research literature